You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
|
---|---|
Published in |
Journal of Neuroinflammation, January 2012
|
DOI | 10.1186/1742-2094-9-8 |
Pubmed ID | |
Authors |
Ana María Martín-Moreno, Begoña Brera, Carlos Spuch, Eva Carro, Luis García-García, Mercedes Delgado, Miguel A Pozo, Nadia G Innamorato, Antonio Cuadrado, María L de Ceballos |
Abstract |
Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurologic disease. Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 29% |
Georgia | 3 | 21% |
Denmark | 1 | 7% |
Unknown | 6 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 71% |
Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Scientists | 1 | 7% |
Unknown | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 237 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Germany | 1 | <1% |
France | 1 | <1% |
Canada | 1 | <1% |
India | 1 | <1% |
Japan | 1 | <1% |
Peru | 1 | <1% |
Unknown | 229 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 42 | 18% |
Researcher | 31 | 13% |
Student > Master | 31 | 13% |
Student > Bachelor | 25 | 11% |
Student > Doctoral Student | 18 | 8% |
Other | 38 | 16% |
Unknown | 52 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 35 | 15% |
Medicine and Dentistry | 34 | 14% |
Agricultural and Biological Sciences | 34 | 14% |
Biochemistry, Genetics and Molecular Biology | 21 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 6% |
Other | 36 | 15% |
Unknown | 63 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2023.
All research outputs
#1,173,742
of 25,088,711 outputs
Outputs from Journal of Neuroinflammation
#96
of 2,899 outputs
Outputs of similar age
#7,677
of 257,257 outputs
Outputs of similar age from Journal of Neuroinflammation
#4
of 37 outputs
Altmetric has tracked 25,088,711 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,899 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 257,257 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.